Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2017-09-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
关于流感病毒裂解疫苗获得联合国儿童基金会采购的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a procurement order received by the company's subsidiary from the United Nations Children's Fund. It does not contain financial statements, detailed financial data, or management discussion. It is an operational update related to a contract or order, not a financial report or regulatory filing. The document length is only 582 characters, indicating it is a brief announcement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a business event that does not fit other specific categories.
2017-09-12 Chinese
关于参股公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a business registration change for an affiliated company, including details about capital increase and updated business license information. It does not contain financial statements, audit information, or detailed financial results. It is a regulatory announcement about corporate changes rather than a report or detailed financial disclosure. The document length is short (871 characters), and it is an announcement of a corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-08-30 Chinese
关于为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 华兰生物工程股份有限公司 regarding the provision of a guarantee for a bank loan to its wholly-owned subsidiary. It includes details about the guarantee amount, the subsidiary's financial status, board approval, and independent directors' opinions. The document is short (1331 characters) and focuses on a specific financing-related event (providing a guarantee). It is not a full financial report, audit, or earnings release. It is not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company.
2017-08-20 Chinese
2017年1-6月财务报表
Interim / Quarterly Report Classification · 100% confidence The document is titled as a financial report for the period January to June 2017, specifically "2017 年1-6 月财务报表（未经审计）" which translates to "2017 January to June Financial Statements (Unaudited)". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and changes in shareholders' equity. The presence of comprehensive financial data and analysis for a half-year period indicates this is an interim or quarterly financial report. The document length is substantial (15,000 characters), and it includes actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-20 Chinese
2017年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017年半年度报告' which translates to '2017 Semi-Annual Report'. It contains detailed financial data, business overview, management discussion, and analysis for the half-year period ending June 30, 2017. The content includes financial figures, business segments, product descriptions, and management commentary, which are typical components of an Interim / Quarterly Report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-20 Chinese
2017年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2017 半年度报告摘要' which translates to '2017 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes management discussion and analysis of business performance and financial conditions during the reporting period. The document is about 4445 characters long, which is consistent with a summary of an interim report rather than a full annual report or a brief announcement. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.